COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,082 Articles (22,658 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1870: Articles 18691-18700  | Next

The impact of Spike mutations on SARS-CoV-2 neutralization
Rees-Spear, C., Muir, L., Griffith, S. A., Heaney, J., Aldon, Y., Snitselaar, J., Thomas, P., Graham, C., Seow, J., Lee, N., Rosa, A., Roustan, C., Houlihan, C. F., Sanders, R. W., Gupta, R. K., Cherepanov, P., Stauss, H., Nastouli, E., Doores, K. J., van Gils, M. J., McCoy, L. E.
10.1101/2021.01.15.426849 — Posted: 2021-01-19
An all-solid-state heterojunction oxide transistor for the rapid detection of biomolecules and SARS-CoV-2 spike S1 protein
Lin, Y.-H., Han, Y., Sharma, A., AlGhamdi, W. S., Liu, C.-H., Chang, T.-H., Xiao, X.-W., Seitkhan, A., Mottram, A. D., Pattanasattayavong, P., Faber, H., Heeney, M., Anthopoulos, T. D.
10.1101/2021.01.19.427256 — Posted: 2021-01-19
Interferon-regulated genetic programs and JAK/STAT pathway activate the intronic promoter of the short ACE2 isoform in renal proximal tubules
Jankowski, J., Lee, H. K., Wilflingseder, J., Hennighausen, L.
10.1101/2021.01.15.426908 — Posted: 2021-01-19
Comprehensive mapping of SARS-CoV-2 interactions in vivo reveals functional virus-host interactions
Wan, Y., Yang, S. L., DeFalco, L., Anderson, D. E., Zhang, Y., Aw, A. J., Lim, S. Y., Lim, X. N., Tan, K. Y., Zhang, T., Chawla, T., Su, Y., Lezhava, A., Sessions, P. d., Merits, A., Wang, L.-F., Huber, R. G.
10.1101/2021.01.17.427000 — Posted: 2021-01-19
Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19/AZD1222 vaccine
Watanabe, Y., Mendonca, L., Allen, E. R., Howe, A., Lee, M., Allen, J. D., Chawla, H., Pulido, D., Donnellan, F., Davies, H., Ulaszewska, M., Belij-Rammerstorfer, S., Morris, S., Krebs, A.-S., Dejnirattisai, W., Mongkolsapaya, J., Supasa, P., Screaton, G. R., Green, C. M., Lambe, T., Zhang, P., Gilbert, S. C., Crispin, M.
10.1101/2021.01.15.426463 — Posted: 2021-01-19
Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
Furuyama, W., Shifflett, K., Pinksi, A. N., Griffin, A. J., Feldmann, F., Okumura, A., Gourdine, T., Jankeel, A., Lovaglio, J., Hanley, P. W., Thomas, T., Clancy, C. S., Messaoudi, I., O'Donnell, K. L., Marzi, A.
10.1101/2021.01.19.426885 — Posted: 2021-01-19
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., Yang, Z., Abernathy, M. E., Huey-Tubman, K. E., Hurley, A., Turroja, M., West, K. A., Gordon, K., Millard, K. G., Ramos, V., Silva, J. D., Xu, J., Colbert, R. A., Patel, R., Dizon, J. P., Unson-O'Brien, C., Shimeliovich, I., Gazumyan, A., Caskey, M., Bjorkman, P. J., Casellas, R., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C.
10.1101/2021.01.15.426911 — Posted: 2021-01-19 Discussion: Onsite
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Muik, A., Wallisch, A.-K., Saenger, B., Swanson, K. A., Muehl, J., Chen, W., Cai, H., Sarkar, R., Tuereci, O., Dormitzer, P. R., Sahin, U.
10.1101/2021.01.18.426984 — Posted: 2021-01-19 Discussion: Onsite | Offsite
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Lambson, B. E., Vermeulen, M., van den Berg, K., Rossouw, T., Boswell, M., Ueckermann, V., Meiring, S., von Gottberg, A., Cohen, C., Morris, L., Bhiman, J. N., Moore, P. L.
10.1101/2021.01.18.427166 — Posted: 2021-01-19 Discussion: Onsite
A national analysis of trends in COVID-19 infection and clinical management in Veterans Health Administration medical facilities
Aboumrad, M., Shiner, B., Riblet, N., Huizenga, H., Neupane, N., Young-Xu, Y.
10.1101/2021.01.18.427092 — Posted: 2021-01-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).